Table 4. Summary of chemotherapy tolerability. Bracketed figures are percentage values.

Regimen	Number	SD chemotherapy commenced	Dose reductions	Six cycles SD received	Three cycles of intended dose chemotherapy received	2 week+ delays	≥grade 3 toxicity	Deaths
Total Patients	87	61 (70)	28 (32)	26 (30)	54 (62)	15 (17)	20 (23)	4 (5)
Anthracyclines	25	21 (84)	4 (16)	9 (36)	16 (64)	3 (12)	7 (28)	2 (8)
Capecitabine	31	20 (65)	18 (58)	9 (29)	20 (64.5)	7 (23)	9 (29)	1 (3)
Taxanes	21	10 (48)	4 (19)	3 (14)	13 (62)	3 (14)	2 (10)	1 (4)
Others	10	10 (100)	2 (29)	5 (50)	5 (50)	2 (20)	2 (29)	0 (0)